Northern Trust
HCAT icon

Northern Trust’s Health Catalyst HCAT Stock Holding History

Northern Trust’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
177,158
-316,688
-64% -$457K ﹤0.01% 3760
2026
Q1 		$627K Buy
493,846
+17,799
+4% +$33.5K ﹤0.01% 3523
2025
Q4 		$1.14M Sell
476,047
-52,764
-10% -$144K ﹤0.01% 3305
2025
Q3 		$1.51M Buy
528,811
+1,841
+0.3% +$6.3K ﹤0.01% 3189
2025
Q2 		$1.99M Buy
526,970
+27,830
+6% +$109K ﹤0.01% 2996
2025
Q1 		$2.26M Sell
499,140
-27,467
-5% -$145K ﹤0.01% 2853
2024
Q4 		$3.72M Buy
526,607
+41,298
+9% +$329K ﹤0.01% 2684
2024
Q3 		$3.95M Buy
485,309
+1,382
+0.3% +$9.99K ﹤0.01% 2616
2024
Q2 		$3.09M Sell
483,927
-28,172
-6% -$181K ﹤0.01% 2662
2024
Q1 		$3.86M Sell
512,099
-9,016
-2% -$82.3K ﹤0.01% 2628
2023
Q4 		$4.83M Sell
521,115
-6,062
-1% -$49.5K ﹤0.01% 2543
2023
Q3 		$5.34M Buy
527,177
+536
+0.1% +$6.4K ﹤0.01% 2405
2023
Q2 		$6.58M Buy
526,641
+22,149
+4% +$264K ﹤0.01% 2345
2023
Q1 		$5.89M Sell
504,492
-10,934
-2% -$139K ﹤0.01% 2355
2022
Q4 		$5.48M Buy
515,426
+25,893
+5% +$250K ﹤0.01% 2426
2022
Q3 		$4.75M Sell
489,533
-14,476
-3% -$192K ﹤0.01% 2517
2022
Q2 		$7.3M Sell
504,009
-61,458
-11% -$1.05M ﹤0.01% 2261
2022
Q1 		$14.8M Sell
565,467
-32,554
-5% -$924K ﹤0.01% 1894
2021
Q4 		$23.7M Buy
598,021
+1,531
+0.3% +$69.8K ﹤0.01% 1648
2021
Q3 		$29.8M Buy
596,490
+54,615
+10% +$2.98M 0.01% 1489
2021
Q2 		$30.1M Buy
541,875
+80,421
+17% +$4.28M 0.01% 1591
2021
Q1 		$21.6M Sell
461,454
-19,308
-4% -$935K ﹤0.01% 1763
2020
Q4 		$20.9M Sell
480,762
-865
-0.2% -$31.9K ﹤0.01% 1753
2020
Q3 		$17.6M Buy
481,627
+134,066
+39% +$4.55M ﹤0.01% 1733
2020
Q2 		$10.1M Buy
347,561
+135,651
+64% +$3.75M ﹤0.01% 2084
2020
Q1 		$5.54M Buy
211,910
+96,458
+84% +$2.95M ﹤0.01% 2237
2019
Q4 		$4.01M Buy
115,452
+7,070
+7% +$234K ﹤0.01% 2716
2019
Q3 		$3.43M Buy
+108,382
New +$4.27M ﹤0.01% 2776

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust's HCAT Position: Q2 2026 in Review

Northern Trust reduced its Health Catalyst (HCAT) stake by 64% in Q2 2026, selling an estimated $457K and leaving 177,158 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #3760.

Northern Trust first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $30.1M in Q2 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Northern Trust held 177,158 shares of Health Catalyst worth $353K as of Q2 2026.
  • Northern Trust sold 316,688 Health Catalyst shares in Q2 2026, an estimated $457K.
  • Health Catalyst made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3760 holding.
  • Northern Trust first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
  • Northern Trust's Health Catalyst position peaked at $30.1M in Q2 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.